Table 2.
Demographics, 10-year CVD risk scores at baseline and post-program, and change in cardiorespiratory fitness for each individual ACR-risk
| N | Age (yrs) | Sex | MetS component (s) | BL 10-yr CVD risk (%) | PP 10-yr CVD risk (%) | Change CR fitness (%) |
|---|---|---|---|---|---|---|
| 1 | 55 | Men | Elevated WC | 4 | 3 | 4.3 |
| 2 | 45 | Men | Elevated WC/BP* | 3 | 3 | 7.3 |
| 3 | 62 | Men | Elevated BP | 10 | 9 | 18.3 |
| 4 | 52 | Men | Elevated BP | 2 | 2 | 4.6 |
| 5 | 79 | Women | Elevated TG | 2 | 2 | 12.6 |
| 6 | 63 | Women | Elevated TG | 2 | 2 | −5.0 |
| 7 | 63 | Men | Elevated TG | 11 | 13 | 20.8 |
| 8 | 48 | Men | Elevated TG | 2 | 2 | 8.9 |
| 9 | 55 | Men | Elevated TG | 6 | 4 | 22.2 |
| 10 | 58 | Women | Elevated TG | 1 | 1 | 1.8 |
| 11 | 46 | Men | Elevated TG | 4 | 4 | 13.6 |
| 12 | 65 | Men | Elevated TG | 11 | 10 | −9.1 |
| 13 | 51 | Men | Low HDL-C | 3 | 5 | 0.5 |
| 14 | 55 | Men | Low HDL-C | 9 | 8 | 20.6 |
| 15 | 63 | Women | Low HDL-C | 2 | 2 | 13.5 |
| 16 | 77 | Men | Low HDL-C | 16 | 15 | 0.3 |
| 17 | 57 | Men | Low HDL-C | 7 | 8 | 5.7 |
| 18 | 79 | Men | IFG | 30 | 30 | 13.3 |
| 19 | 61 | Women | IFG | 2 | 2 | 1.8 |
| 20 | 56 | Women | IFG | 0 | 0 | 5.7 |
| 21 | 63 | Women | IFG | 1 | 0 | 11.1 |
| 22 | 45 | Men | IFG | 3 | 3 | 7.3 |
| Mean | 59.0 | – | – | 6.0 | 5.8 | 8.2 |
| SD | 10.0 | – | – | 6.8 | 6.8 | 8.3 |
Notes:
*
Denotes multiple ACR-risk. ACR-risk: adverse cardiometabolic response who gained a metabolic syndrome component.
Abbreviations: ACR, exercise-induced adverse cardiometabolic response; MetS, metabolic syndrome; EE, energy expenditure; CR, cardiorespiratory; WC, waist circumference; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; IFG, impaired fasting blood glucose; CVD, cardiovascular disease; yr, year; BL, baseline; PP, post-program; SD, standard deviation.